Vertex CEO Jeffrey Leiden has offered an olive branch to negotiators in the UK that could see the cystic fibrosis drug Orkambi finally supplied to patients in England.

A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

In May 2022, Vertex opened the 270,000-square-foot Jeffrey Leiden Center for Cell and Genetic Therapies at the corner of Northern Avenue and Tide Street, and announced plans to expand into an even ...

The NICE-Vertex saga continued this month with Vertex’s CEO Jeffrey Leiden hinting at ‘new ideas’ to bring cystic fibrosis drug Orkambi to UK patients. Leiden said that he is to meet with ...